THE RESISTIN LEVELS CHANGES IN HYPERTENSIVE PATIENTS IN DEPENDSE ON CONCOMITANT DIABETES MELLITUS TYPE 2 AND INSULIN RESISTANCE
DOI:
https://doi.org/10.21856/j-PEP.2011.1.03Keywords:
resistin, diabetes mellitus type 2, insulin resistanceAbstract
The levels of resistin are studied on the background of insulin resistance or at presence of diabetes mellitus type 2 in patients with arterial hypertension, that is actual for introduction of new approaches in the estimation of insulin resistance, and for the account of resistin effects on metabolic processes at the choice of therapeutic methods, aimed at the decline of expressed of insulin resistance of peripheral tissue.
References
Целуйко В. И. Метаболический синдром [Текст] / В. И. Целуйко, В. А. Чернышов, Л. Т. Малая. — Х., 2002. — С. 10–16.
Артериальная гипертония при метаболическом синдроме: патогенез, основы терапии [Текст] / В. С. Задионченко, Т. В. Адашева, О.Ю. Демичева [и др.] // Consilium medicum. — 2004. — Vol. 6. — № 9. — С. 17–19.
Richard N. Redinger The Pathophysiology of Obesity and Its Clinical Manifestations [Text] / Richard N. Redinger // Gastroenterology and Hepatology. — 2007. — Vol. 31. — P. 856–863.
Higher production of IL-8 in visceral vs. subcutaneous adipose tissue. Implication of nonadipose cells in adipose tissue [Text] / J. M. Bruun, A. S. Lihn, A. K. Madan [et al.] // Amer. J. Physiol. Endocrinol. Metabol. — 2004. — Vol. 286. — P. 8–13.
Чубриева С.Ю. Жировая ткань как эндокринный регулятор [Teкст] / С.Ю. Чубриева, Н. В. Глухов, А. М. Зайчик // Вестник Санкт-Петербур. ун-та. — 2008. — Сер. 11. — Вып. 1. — C. 32–43.
Resistin levels in human immunodeficiency virus-infected patients with lipoatrophy decrease in response to rosiglitazone [Text] / D. Kamin, C. Hadigan, M. Lehrke [et al.] // J. Clin. Endocrinol. Metabol. — 2005. — Vol. 90. — P. 3423–3426.
Associations of adiponectin, resistin, and tumor necrosis factor — with insulin resistance [Text] / M. F. Hivert, L. M. Sullivan, C. S. Fox [et al.] // J. Clin. Endocrinol. Metabol. — 2008. — Vol. 93. — P. 3165–3172.
Serum resistin is not associated with obesity or insulin resistance in humans [Text] / N. Iqbal, P. Seshadri, L. Stern [et al.] // Europ. Rev. Med Pharmacol. Scien. — 2005. — Vol. 9. — P. 161–165.
Майоров А. Ю. Состояние инсулинорезистентности в эволюции сахарного диабета 2 типа [Tекст]: автореф. дис. д-ра мед. наук / А. Ю. Майоров. — М., 2007. — 60 с.
Plasma resistin levels correlate with determinants of the metabolic syndrome [Text] / G. D. Norata, M. Ongari, K. Garlaschelli [et al.] // Europ. J. Endocrinol. — 2006. — Vol. 156. — Р. 279–284.
Pischon T. Use of obesity biomarkers in cardiovascular epidemiology [Text] / T. Pischon // Dis Markers. — 2009. — Vol. 26 (5–6). — P. 247–263.
2007 Guidelines for the management of arterial hypertension [Text] // J. Hypertension. — 2007. — Vol. 25. — P. 1105–1187.
Лапач С. Н. Статистические методы в медико-биологических исследованиях с использованием Excel [Teкст] / С. Н. Лапач, А. В. Губенко, П. Н. Бабич // К.: Морион, 2001. — 408 с.
Identification of RELM-?, a novel resistin-like molecule with a distinct expression pattern [Text] / B. Gerstmayer, D. Kusters, S. Gebel [et al.] // Genomics. — 2003. — Vol. 81. — P. 588–595.
Heritability of Serum Resistin and Its Genetic Correlation with Insulin Resistance-Related Features in Nondiabetic Caucasians [Text] / C. Menzaghi, A. Coco, L. Salvemini [et al.] // J. Clin. Endocrinol. Metabol. — Vol. 91. — № 7. — P. 2792–2795.
Roles of adipocyte derived hormone adiponectin and resistin in insulin resistance of type 2 diabetes [Text] / Hui-Ling Lu, Hong-Wei Wang, Yu Wen [et al.] // World J. Gastroenterol. — 2006. — Vol. 12 (11). — P. 1747–1751.
Cederberg A. Insulin resistance and type 2 diabetes an adipocentric view [Text] / A. Cederberg, S. Enerback // Curr. Mol. Med. — 2003. — Vol. 3. — P. 107–125.
ISSN 
ISSN 
